- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NO3: NITRATE ION(Non-functional Binders)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 5 residues within 4Å:- Chain A: L.75, K.76, L.78, K.85, I.86
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: K.76, I.86, K.87, N.88, F.89
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: K.263, F.273, E.277, R.280, H.281, P.282
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: E.17, N.88, F.89, F.90
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: R.144, V.206
- Chain B: V.193
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: E.277, R.280
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: Q.134, E.276, L.279, R.280
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.38, K.39
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: E.227, S.233, L.234, K.235
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain B: L.75, K.76, L.78, K.85, I.86
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain B: K.76, I.86, K.87, N.88, F.89
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: K.263, F.273, E.277, R.280, H.281, P.282
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain B: E.17, N.88, F.89, F.90
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: V.193
- Chain B: R.144, V.206
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Chain B: E.277, R.280
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain B: Q.134, E.276, L.279, R.280
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: R.38, K.39
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: E.227, S.233, L.234, K.235
Ligand excluded by PLIP- 2 x A9U: 2-{4-[(1-BENZYLPIPERIDIN-4-YL)METHOXY]PHENYL}-1H-BENZIMIDAZOLE-6-CARBOXAMIDE(Non-covalent)
A9U.3: 12 residues within 4Å:- Chain A: L.24, V.32, K.47, L.99, M.102, E.103, G.105, E.106, L.152, Q.156, T.165, D.166
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.24, A:L.24, A:V.32, A:L.99, A:L.152, A:T.165
- Hydrogen bonds: A:K.47, A:E.106, A:E.106, A:D.166
- Water bridges: A:F.167
A9U.15: 12 residues within 4Å:- Chain B: L.24, V.32, K.47, L.99, M.102, E.103, G.105, E.106, L.152, Q.156, T.165, D.166
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:L.24, B:L.24, B:V.32, B:L.99, B:L.152, B:T.165
- Hydrogen bonds: B:K.47, B:E.106, B:D.166, B:D.166
- Water bridges: B:F.167
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matijssen, C. et al., Benzimidazole Inhibitors of the Protein Kinase Chk2: Clarification of the Binding Mode by Flexible Side Chain Docking and Protein-Ligand Crystallography. Bioorg.Med.Chem. (2012)
- Release Date
- 2012-10-10
- Peptides
- SERINE/THREONINE-PROTEIN KINASE CHK2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.48 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NO3: NITRATE ION(Non-functional Binders)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x A9U: 2-{4-[(1-BENZYLPIPERIDIN-4-YL)METHOXY]PHENYL}-1H-BENZIMIDAZOLE-6-CARBOXAMIDE(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matijssen, C. et al., Benzimidazole Inhibitors of the Protein Kinase Chk2: Clarification of the Binding Mode by Flexible Side Chain Docking and Protein-Ligand Crystallography. Bioorg.Med.Chem. (2012)
- Release Date
- 2012-10-10
- Peptides
- SERINE/THREONINE-PROTEIN KINASE CHK2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A